Clinical application of proteomics approaches in vascular diseases

Xiao-Li Wang1, Alex Fu, Craig Spiro

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. wang.xiaoli@mayo.edu.

Insights

Proteomics offers new insights into cardiovascular diseases by revealing complex protein changes. This approach helps understand vascular dysfunction and advance treatments for these leading causes of death.

Area of Science:

  • Cardiovascular science
  • Molecular biology
  • Proteomics

Background:

  • Cardiovascular diseases are a major cause of death globally.
  • Current understanding of vascular dysfunction remains incomplete.
  • Elucidating molecular interactions is crucial for treatment progress.

Purpose of the Study:

  • To review the application of proteomics in understanding vascular diseases.
  • To highlight how proteomics can advance the study of vascular dysfunction mechanisms.

Main Methods:

  • Proteomic techniques for identifying protein changes.
  • Analysis of intracellular processes in vascular regulation.

Main Results:

  • Proteomics reveals dynamic and subtle intracellular changes in vascular dysfunction.
  • Novel insights into molecular mechanisms underlying vascular diseases.

Conclusions:

  • Proteomics is a powerful tool for studying cardiovascular diseases.
  • Further application of proteomics will enhance understanding and treatment of vascular dysfunction.

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...